Unique chemical derivatives invented by University of Kansas (KU) researchers that could be used to detect inhibitors of cellular efflux transporters and other agents.
The present invention provides decellularized cartilage (DCC) fragments or powder as a raw material component to be utilized for scaffolds and provides a microenvironment similar to that of native cartilage tissue. The DCC powder provides a platform technology upon which many cartilage, or even bone, tissue engineering scaffolds could be based.
The invention relates to protecting against Salmonella-type pathogens and more particularly, compositions and methods for immunizing against infection by typhoidal and non-typhoidal Salmonella serovars.
Novel chemical compounds for use as antivirals against VEEV and other alpha viruses.
This invention includes novel methods for creating and isolating regulatory T cells (Tregs) for use in adoptive immunotherapy.
Implantable biomaterial for promoting bone and cartilage regeneration in joints following articular cartilage injury, a leading cause of advanced osteoarthritis.
The invention is a novel synthesis procedure to create hydrogels with mechanical properties desirable for musculoskeletal tissue engineering.
This invention entails a novel, nonhormonal compound that can sterilize both male and female companion animals in a single dose.
KU researchers have developed a biomimetic scaffold for tracheal tissue regeneration, using polycaprolactone (PCL) electrospun fibers.